1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. PureTech Health plc
  6. News
  7. Summary
    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC

(PRTC)
  Report
Delayed London Stock Exchange  -  11:35 2022-08-12 am EDT
236.00 GBX   +3.96%
08/09PURETECH HEALTH : PureTech To Receive up to Approximately $115.4 Million from Sale of a Portion of Founded Entity Shares - Form 6-K
PU
08/09SVB Securities Adjusts PureTech Health's Price Target to $70 from $66, Keeps Outperform Rating
MT
08/09PureTech Health Reports $115 Million Proceeds from Karuna Therapeutics Equities Sale
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PureTech Health's Founded Entity Gelesis to Go Public via Merger with Capstar

01/14/2022 | 07:46am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
CAPR SPEC 0.62% 1.63 Delayed Quote.-83.63%
PURETECH HEALTH PLC 3.96% 236 Delayed Quote.-19.18%
All news about PURETECH HEALTH PLC
08/09PURETECH HEALTH : PureTech To Receive up to Approximately $115.4 Million from Sale of a Po..
PU
08/09SVB Securities Adjusts PureTech Health's Price Target to $70 from $66, Keeps Outperform..
MT
08/09PureTech Health Reports $115 Million Proceeds from Karuna Therapeutics Equities Sale
MT
08/08PureTech's Minority-Owned Karuna Meets Primary, Secondary Endpoints in Schizophrenia Th..
MT
08/04PURETECH HEALTH : Notice of Half-Yearly Results
BU
08/01PureTech Health Says Akili Starts Phase 3 Study of SDT-001 in Japan to Treat Children W..
MT
08/01PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children ..
BU
08/01PureTech Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Sh..
CI
07/14PureTech Founded Entity Akili Announces the Journal Lupus Publishes Investigator-Initia..
BU
07/14PureTech Health plc Announces New Akili Data in Lupus
CI
More news
Analyst Recommendations on PURETECH HEALTH PLC
More recommendations
Financials (USD)
Sales 2022 11,9 M - -
Net income 2022 -158 M - -
Net cash 2022 370 M - -
P/E ratio 2022 -5,61x
Yield 2022 -
Capitalization 814 M 814 M -
EV / Sales 2022 37,3x
EV / Sales 2023 38,5x
Nbr of Employees 95
Free-Float 84,8%
Chart PURETECH HEALTH PLC
Duration : Period :
PureTech Health plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 2,86 $
Average target price 8,00 $
Spread / Average Target 180%
EPS Revisions
Managers and Directors
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, Chief Operating Officer & Director
George Farmer Chief Financial Officer
Christopher A. Viehbacher Chairman
Joseph B. Bolen Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
PURETECH HEALTH PLC-19.18%814
MODERNA, INC.-32.60%66 966
IQVIA HOLDINGS INC.-12.88%45 846
LONZA GROUP AG-25.13%44 851
SEAGEN INC.10.05%31 380
ALNYLAM PHARMACEUTICALS, INC.37.90%28 068